R-MVST Cells for Treatment of Viral Infections
NCT05183490
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Epstein-Barr Virus Infections
Cytomegalovirus Infections
Adenovirus
BK Virus Infection
Interventions
DRUG:
Rapidly generated virus specific T (R-MVST) cells
Sponsor
Columbia University